BioCentury
ARTICLE | Company News

Biotecnol Inc., PolyTherics deal

October 29, 2012 7:00 AM UTC

Biotecnol and PolyTherics partnered to develop multi-specific Tribody drug conjugates to treat cancer. The companies will use PolyTherics' ThioBridge conjugation technology to attach cytotoxic drugs o...